UL1TR002649
Cooperative Agreement
Overview
Grant Description
Center for Clinical and Translational Research
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Virginia
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 403% from $3,570,579 to $17,977,705.
Virginia Commonwealth University was awarded
Center for Clinical and Translational Research
Cooperative Agreement UL1TR002649
worth $17,977,705
from National Center for Advancing Translational Sciences in May 2018 with work to be completed primarily in Virginia United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (U54).
Status
(Complete)
Last Modified 1/25/24
Period of Performance
5/8/18
Start Date
4/30/23
End Date
Funding Split
$18.0M
Federal Obligation
$0.0
Non-Federal Obligation
$18.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for UL1TR002649
Transaction History
Modifications to UL1TR002649
Additional Detail
Award ID FAIN
UL1TR002649
SAI Number
UL1TR002649-3119148056
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Funding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Awardee UEI
MLQFL4JSSAA9
Awardee CAGE
46050
Performance District
VA-90
Senators
Mark Warner
Timothy Kaine
Timothy Kaine
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) | Health research and training | Grants, subsidies, and contributions (41.0) | $22,519,798 | 98% |
Modified: 1/25/24